DuPont de Nemours, Inc.

Company facts

Industry

Plastic Materials, Synth Resins & Nonvulcan Elastomers

Headquarters

Wilmington, Delaware

Most recent report

10-Q, filed Aug 4, 2026

Incorporated

Delaware

Filings on record

1,009+ filings

On EDGAR

CIK 1666700

Fiscal year ends

December

Filer status

Large accelerated filer

What to read: Jun 2026 10-Q

SECSift found 2 of 8 sections worth reading, with 0 positive, 4 notable, and 2 negative flags.

• Part I

  Financials, notes, and MD&A with major PFAS liabilities and strong earnings swing.
  Notable

  • Reverse stock split 1-for-3 effective June 24, 2026; authorized shares reduced to 556M.
  • Aramids divestiture closed April 1, 2026; DuPont received $1.2B cash, $300M note, 16% equity.
  • Q2 2026 ASR completed: repurchased 1.8M shares at $148.91 avg price for $275M.
  Negative

  • ~12,400 personal injury cases in AFFF MDL at June 30, up from ~11,900 at March 31.
  • New $125M accrual for North Carolina PFAS matters, recorded in Q2 2026.

• Management's Discussion (Item 2)

  Specific share repurchase and reverse stock split with dollar amounts.
  Notable

  • Effected a 1-for-3 reverse stock split on June 24, 2026.

What changed: Jun 2026 vs. Mar 2026

About 15% of DD's Jun 2026 10-Q is new information. 68 paragraphs were added, 178 changed, and 35 removed. Below are the most important lines SECSift identified.

• Part I 189
• Item 2 4
• Item 6 1
• Item 5 1